Cargando…
HES1, a target of Notch signaling, is elevated in canine osteosarcoma, but reduced in the most aggressive tumors
BACKGROUND: Hairy and enhancer of split 1 (HES1), a basic helix-loop-helix transcriptional repressor, is a downstream target of Notch signaling. Notch signaling and HES1 expression have been linked to growth and survival in a variety of human cancer types and have been associated with increased meta...
Autores principales: | Dailey, Deanna D, Anfinsen, Kristin P, Pfaff, Liza E, Ehrhart, EJ, Charles, J Brad, Bønsdorff, Tina B, Thamm, Douglas H, Powers, Barbara E, Jonasdottir, Thora J, Duval, Dawn L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3701487/ https://www.ncbi.nlm.nih.gov/pubmed/23816051 http://dx.doi.org/10.1186/1746-6148-9-130 |
Ejemplares similares
-
HES6 promotes prostate cancer aggressiveness independently of Notch signalling
por: Carvalho, Filipe L F, et al.
Publicado: (2015) -
Evaluation of CD146 as Target for Radioimmunotherapy against Osteosarcoma
por: Westrøm, Sara, et al.
Publicado: (2016) -
MicroRNA Expression Changes and Integrated Pathways Associated With Poor Outcome in Canine Osteosarcoma
por: Dailey, Deanna D., et al.
Publicado: (2021) -
Regulation of NOTCH Signaling by Reciprocal Inhibition of HES1 and Deltex 1 and its Role in Osteosarcoma Invasiveness
por: Zhang, Pingyu, et al.
Publicado: (2010) -
The Notch signaling pathway controls CD8(+) T cell differentiation independently of the classical effector HES1
por: De Sousa, Dave Maurice, et al.
Publicado: (2019)